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Bone Metastasis with Histology 
Different from The Primary Lung 
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A	 60-year-old	 heavy	 smoker	 female	 (pack-year	 index:	 38)	 was	
admitted	to	the	Department	of	Pulmonology	of	the	Semmelweis	
University	 in	 June	 2013,	 after	 surgery	 because	 of	 pathologic	
fracture	 due	 to	 right	 pelvic	 lytic	 metastasis.	 Histologically,	
the	 pelvic	 tumor	 mass	 proved	 to	 be	 a	 poorly	 differentiated	
adenocarcinoma	 with	 codon	 12	 point	 mutation	 of	 the	 KRAS	
gene	 (glycine	 (GGT)	 to	 valine	 (GTT)	 conversion)	 characteristic	
for	 smoking-related	 genetic	 changes.	 The	 method	 used	 for	
KRAS	 mutation	 analysis	 has	 already	 been	 described	 in	 our	
previous	work	by	Cserepes	et	al.	[3].	Bronchoscopy	revealed	an	
endobronchially	 visible	 tumor	 in	 the	 right	 lower	 lobe	bronchus	
that	was	diagnosed	histologically	as	a	TTF-1	(thyroid	transcription	
factor-1)	 negative	 and	 p63	 positive	 squamous	 cell	 carcinoma,	
and	 was	 regarded	 as	 the	 primary	 tumor.	 Thoracic	 CT	 showed	
paratracheal	lymph	node	enlargement	and	a	small,	lobular	right	
upper	 lobe	nodule	both	regarded	as	metastases.	Abdominal	CT	
scan	 showed	 enlarged	 left	 adrenal	 gland	 referring	 to	 adrenal	
metastasis.	 Two	 weeks	 after	 her	 admission,	 rapidly	 growing	
multiple	cystic	subcutaneous	nodules	with	inflammatory	changes	




The	 general	 condition	 of	 the	 patient	 deteriorated	 rapidly	 and	
she	died	5	weeks	after	her	admission	even	without	having	 the	
opportunity	 to	 receive	 palliative	 oncotherapy.	 In	 summary,	 in	
this	 patient	 both	 the	 primary	 tumor	 and	 the	 subcutaneous	
metastases	were	squamous	cell	carcinomas;	however,	the	pelvic	
bone	 metastasis	 proved	 to	 be	 an	 anaplastic	 adenocarcinoma.	
Neither	thoracic	CT	nor	bronchoscopy	showed	any	other	 lesion	














In	 the	 presented	 case	 we	 might	 speculate	 that	 the	 right	 lower	
lobe	 endobronchial	 tumor	 contained	 adenosquamous	 elements,	
and	during	the	metastatic	process	a	tumor	cell	selection	occurred	




variation	 including	 clonal	 selection,	 parallel	 evolution,	 dynamic	
heterogeneity,	 clonal	 dominance	 and	 stem	 cell	 expansion	 [4].	 In	
lung	adenocarcinoma,	the	prognostic	significance	of	KRAS	mutation	
has	 already	 been	 documented	 [5].	 The	 correlation	 between	
primary	 tumor	and	bone	metastasis	 in	non-small	 cell	 lung	 cancer	
was	 investigated	 by	 Badalian	 et	 al,	who	 demonstrated	 that	 KRAS	
mutational	status	of	the	primary	tumor	did	not	predict	the	status	of	
the	bone	metastatic	tissue,	since	they	had	observed	both	emergence	
of	mutant	 clones	 in	metastases	 from	wild-type	 primary	 tumors	
and	loss	of	mutant	clones	in	metastases	from	mutant	primaries	
in	addition	to	the	maintained	mutant	status	[6].	




could	 have	 contributed	 to	 an	 artificial	 selection	 pressure	 for	






could	 be	 demonstrated.	 The	 skin	 involvement	 had	 the	 same	
squamous	 cell	 carcinoma	histology	as	 the	primary	 lung	 cancer,	
while	the	bone	metastasis	was	found	to	be	an	adenocarcinoma	
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